Literature DB >> 18781611

Adsorption and function of recombinant Factor VIII at the air-water interface in the presence of Tween 80.

Omkar Joshi1, Liping Chu, Joseph McGuire, D Q Wang.   

Abstract

The air-water surface tension kinetic and steady state behavior exhibited by a recombinant Factor VIII were recorded in the presence of the surfactant Tween 80. The rate of surface tension decrease was determined to be greater for rFVIII-Tween mixtures than for Tween acting alone, at all Tween concentrations studied (8-108 ppm). In addition, steady state interfacial behavior was determined to be governed entirely by surfactant adsorption in mixtures with Tween concentrations greater than or equal to about 18 ppm. The formation of aggregates, tertiary structure change, and biological activity of rFVIII in agitated as well as unagitated samples were monitored using turbidity measurements, intrinsic fluorescence spectroscopy, and the activated partial thromboplastin time, respectively. The results are consistent with two mechanisms characterizing the surfactant-mediated stabilization of rFVIII: the rapid, preferential adsorption of Tween molecules relative to rFVIII molecules at the air-water interface, and Tween association with rFVIII in solution to provide a steric barrier to aggregation. While both mechanisms are relevant in the presence of an interface, evidence recorded here suggests that the preferential adsorption of Tween at the interface is the major stabilization mechanism while the effectiveness of Tween association with rFVIII is compromised in agitated samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18781611     DOI: 10.1002/jps.21569

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

2.  Evaporative preconcentration of fluorescent protein samples in capillary based microplates.

Authors:  Fenfen Shao; Tuck Wah Ng; Jonathan Kok Keung Lye; Oi Wah Liew
Journal:  J Fluoresc       Date:  2011-05-11       Impact factor: 2.217

3.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

4.  The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions.

Authors:  Tim Serno; Elisabeth Härtl; Ahmed Besheer; Reinhard Miller; Gerhard Winter
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

5.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

6.  Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.

Authors:  Alana Gerhardt; Aaron C Mcumber; Bao H Nguyen; Rachael Lewus; Daniel K Schwartz; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-09-28       Impact factor: 3.534

7.  Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.

Authors:  Neha N Pardeshi; Chen Zhou; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2018-03-27       Impact factor: 3.534

8.  Protein-Stabilizing Effect of Amphiphilic Block Copolymers with a Tertiary Sulfonium-Containing Zwitterionic Segment.

Authors:  Ryutaro Imamura; Hideharu Mori
Journal:  ACS Omega       Date:  2019-10-22

Review 9.  Immunogenicity of therapeutic proteins: influence of aggregation.

Authors:  Kirsty D Ratanji; Jeremy P Derrick; Rebecca J Dearman; Ian Kimber
Journal:  J Immunotoxicol       Date:  2013-08-06       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.